NIH scientists are initiating Phase 1 / 2 studies of a new DNA-based vaccine despite the FDA’s acknowledgment that technology that allows for the creation of these new vaccines has outpaced their ability to predict adverse events.
[Source: childrenshealthdefense.org] [ Comments ] [See why this is trending]